Tumors with BRCAness—tumors that share molecular features of germline BRCA1/2-mutant cancers—may share therapeutic vulnerabilities with BRCA1/2 mutant cancers to PARPi treatment [35,36]. The gene discussed is BRCA1; the disease is cancer.